People
YS Biopharma Announces Appointment of New Directors
In addition to the new appointments, the Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board
Cantor Fitzgerald Bolsters Healthcare and Biotechnology Equity Research Team with Addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D.
Cantor Fitzgerald, L.P., ("Cantor") a leading global financial services firm, today announced the addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D., to its Healthcare and Biotechnology Research platform.
Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non-Executive Director
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology announced the appointment of Dr. Albert R. Collinson as independent non-executive director.
Innoforce Strengthens Commercialization Leadership and Announces the Appointment of a New Chief Executive Officer
Zhejiang Innoforce Pharmaceuticals Co., Ltd. ("Innoforce"), a CDMO company dedicated to providing one-stop-shop services to Advanced Therapy Medicinal Product (ATMP) customers and partners, today announced Dr. Dewan Zeng as the new Chief Executive Officer, effective immediately.
Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development
Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that Dr. Francois Lebel, M.D., an experienced biopharmaceutical industry executive, has been appointed as Senior Vice President for preclinical and clinical development of the Group.
Qihan Biotech Appoints Naxin Yao to its Board of Directors
Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced today the appointment of Mr. Naxin Yao, as an independent director to its Board of Directors.
CBC Group Appoints Billy Cho as Senior Managing Director, Private Equity and Co-Head, Joint Value Creation
CBC Group (“CBC”), Asia’s largest healthcare-dedicated investment firm headquartered in Singapore, today announced the appointment of Billy Cho as Senior Managing Director, Private Equity and Co-Head, Joint Value Creation.
HUTCHMED Announces Changes to Board of Directors and Technical Committee
Ms Ling Yang to replace Mr Lefei Sun as Non-executive Director; Professor Solange Peters appointed as Special Advisor to the Technical Committee
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development
Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company, today announced the appointment of Furqan Ahmed, PharmD., as the Vice President and Head of Business Development. In this position, Furqan will be responsible for all aspects of the company's global business development efforts to maximize the value of Biosion's platforms and innovative pipeline.
Brii Biosciences Provides Latest Clinical Development and Corporate Updates
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today provided updates on its diverse pipeline of infectious disease (ID) and central nervous system (CNS) disease candidates and announced a pivotal leadership transition that will further advance its strategic priorities.
